This first human trial of the vaccine was primarily designed to establish a safety profile for the treatment. Ten patients, with either stage I or II colon cancer, were administered a single shot of the vaccine and followed up for six months...
Read more via New Atlas – http://bit.ly/2vneuQI...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.